Shifting Gears at GrowBLOX Sciences, Inc. (GBLX)
Medical cannabis and cannabinoid-based therapies are gaining wider acceptance around the United States. More than 20 states and the District of Columbia have legalized the drug and, between 2009 and 2014, IBISWorld estimates that the medical cannabis industry grew significantly to reach $2 billion in revenue. Despite this industry boom and the pioneers that emerged within it, there has been a shortage of companies conducting legitimate research and development and/or with the right amount of scientific backing and funding needed to compete in the industry. GrowBLOX Sciences, a biopharmaceutical research and development company, stands out from the pack with its…